SCHEMBL9285950

SCHEMBL9285950

CCOC(=O)CCC(/C(=N\O)c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
F10 P00742 1/20 0.40
TBXAS1 P24557 2/20 0.40
F2 P00734 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9285951 1.00 CYP3A4 (0.42) CYP3A4CYP2D6CYP2C19L3MBTL1GAA
SCHEMBL9258457 0.83 LMNA (0.50) CYP3A4CYP2D6CYP2C19L3MBTL1GAA
SCHEMBL7288615 0.82 MMP8 (0.49) CYP3A4CYP2D6CYP2C19L3MBTL1GAA
SCHEMBL3067053 0.79 EPHX1 (0.49) CYP3A4CYP2D6CYP2C19GAATDP1
SCHEMBL29029672 0.79 SMN1; SMN2 (0.48) L3MBTL1TDP1SMN1; SMN2MEN1NPC1
SCHEMBL28633131 0.77 SMN1; SMN2 (0.51) CYP3A4CYP2D6CYP2C19SMN1; SMN2MEN1
SCHEMBL29029675 0.75 SMN1; SMN2 (0.44) L3MBTL1TDP1SMN1; SMN2MEN1NPC1
SCHEMBL9366743 0.75 LMNA (0.47) TDP1SMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL2512047 0.74 CYP3A4 (0.49) CYP3A4CYP2D6CYP2C19SMN1; SMN2KDM4E
SCHEMBL29069352 0.74 ALDH1A1 (0.52) CYP3A4CYP2D6CYP2C19SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995023135-A1 DIPHENYL-2-PIPERIDINONE AND -2-PYRROLIDINONE DERIVATIVES HAVING ANTI-CONVULSANT AND NEUROPROTECTIVE ACTIVITY FISONS CORPORATION (US) 1995-08-31 WO disclosed